U.S. tissue bank strikes deal for cell removal technology

06/18/2013 | Bloomberg

Community Tissue Services of Dayton, Ohio, will use U.K.-based Tissue Regenix's cell-removal technology to produce decellularized skin, which either company may then distribute in the U.S. The tissue will be used for wound care and burn products, among other uses. The technology allows Tissue Regenix to remove cells from animal tissue, creating a matrix for the patient's own cells to grow without rejecting the tissue.

View Full Article in:

Bloomberg

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Abbott
Chicago, IL
Senior Manager, Compliance
Stryker
Fremont, CA
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA